Walmart Products Recalled Nationwide as Customers Told to Dispose of Items
Two products sold at Walmart have been recalled, with customers being urged to dispose of the items.
Guidance on the product recall page on Walmart's website reads: "Walmart and Sam's Club are committed to the health and safety of our customers and members and to providing products that are safe and compliant, all supported by our health and wellness, product safety, and food safety professionals."
"In the event of a product recall, we work swiftly to block the item from being sold and remove it from our stores and clubs."
Newsweek reached out to Walmart via an online contact form for comment.
Using recalled products or consuming recalled food items can pose serious health risks. Recalls can be initiated for myriad reasons, including undeclared allergens or potential contaminants.
The Consumer Product Safety Commission (CPSC) has announced a recall of approximately 8,560 MaxKare Electric Blankets, sold exclusively online at Walmart.com, between June 2021 and November 2024, for $27 to $80.
The recall targeted models HB18A-7284-1, HB18A-8490-2, and HB18A-6284-1, which were available in three sizes (twin, full, queen) and two colors (brown and gray).
Yumo, which manufactures the blankets, received 34 reports of the blankets overheating, including two reports of blankets catching fire and three reports of burn injuries.
The affected blankets featured six heating levels and a nine-hour auto-off function. Shenzhen Yumo Commerce and Trade Corporation manufactured the blankets in China.
Consumers should immediately stop using the product and are advised to contact Yumo for instructions on how to dispose of it.
Newsweek reached out to Yumo via email for comment.
The U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) issued a recall for FreshRealm's Chicken Fettuccine Alfredo products and is investigating an outbreak of Listeria connected to the recall.
In response to a request for comment, Fresh Realm directed Newsweek to a press release that read in part: "Out of an abundance of caution, FreshRealm is recalling the product while the investigation proceeds. The investigation will focus on how Listeria may have entered the product, and whether it entered from a FreshRealm facility, or through any of the ingredients that FreshRealm received from external ingredient suppliers."
"FreshRealm remains committed to the highest standards of food safety and is working closely with the Food and Drug Administration, the U.S. Department of Agriculture Food Safety and Inspection Service and the Centers for Disease Control and Prevention to provide full transparency and access throughout the process."
The recall affected three different ready-to-eat products:
MARKETSIDE GRILLED CHICKEN ALFREDO WITH FETTUCCINE Tender Pasta with Creamy Alfredo Sauce, White Meat Chicken and Shaved Parmesan Cheese
Details: 32.8oz, best-by—date of 6.27.25, EST. P-50784
MARKETSIDE GRILLED CHICKEN ALFREDO WITH FETTUCCINE Tender Pasta with Creamy Alfredo Sauce, White Meat Chicken, Broccoli and Shaved Parmesan Cheese
Details: 12.3oz, 6.26.25, EST. P-47770
HOME CHEF Heat & Eat Chicken Fettuccine Alfredo with pasta, grilled white meat chicken, and Parmesan cheese
Details: 12.05oz, 6.19.25, EST. P-47718
Consumers who purchased the product are advised to destroy it or return it to the place of purchase for a refund.
The FSIS said in their recall notice that they are "investigating an outbreak of Lm that currently includes 17 ill people in 13 states. As of June 17, 2025, there have been three reported deaths and one fetal loss associated with this outbreak.
"The outbreak strain of Lm was isolated from ill people on dates ranging from August 2024 – May 2025. The same outbreak strain was isolated from a routine chicken fettuccine alfredo sample collected by FSIS in a FreshRealm establishment in March 2025. The lot of chicken fettuccine alfredo represented by this sample was held during sampling, destroyed, and never entered commerce."
The FSIS, on its website: "Listeriosis can cause fever, muscle aches, headache, stiff neck, confusion, loss of balance and convulsions sometimes preceded by diarrhea or other gastrointestinal symptoms. An invasive infection spreads beyond the gastrointestinal tract.
"In pregnant women, the infection can cause miscarriages, stillbirths, premature delivery or life-threatening infection of the newborn. In addition, serious and sometimes fatal infections in older adults and people with weakened immune systems. Listeriosis is treated with antibiotics."
Both recalls are ongoing.
Related Articles
How Recall of 20 Million Eggs Could Affect US PricesWalmart's Post About Grilling Flooded With Negative CommentsWalmart Faces MAGA Boycott After Heiress Funds 'No Kings' AdRetail Layoffs Soar Nearly 300% So Far This Year
2025 NEWSWEEK DIGITAL LLC.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
2 hours ago
- Washington Post
Friday briefing: Trump's Iran decision; National Guard; Dodger Stadium; listeria outbreak; ‘Jaws' 50th anniversary; and more
President Donald Trump will wait as much as two weeks to decide on striking Iran. An appeals court allowed Trump to keep the National Guard in Los Angeles. A man was accused of knocking on the Memphis mayor's door with a Taser. Three people died in a listeria outbreak linked to packaged meals. Plastic bag fees and bans help limit coastal litter, a new study found. Archaeologists spent three months piecing together a huge Roman 'puzzle.' 'Jaws' was released 50 years ago today. And now … hot where you are? Here are five things that may make you feel worse during extreme heat. Want to catch up quickly with 'The 7' every morning? Download The Post's app and turn on alert notifications for The 7 or sign up for the newsletter.
Newsweek
5 hours ago
- Newsweek
New IVF Tool Allows Parents To Screen Genetics of Embryos: Is It Ethical?
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new tool allows parents undergoing in vitro fertilization (IVF) to screen their embryos for health issues, but is it ethical? Genetic disease is believed to be linked to 41 percent of U.S. infants' deaths, while more than 2 million children in the country have a genetic condition. U.S.-based company Nucleus is offering people having IVF the chance to select their embryos by using software that highlights various genetic markers linked to health. Technology that tries to prevent genetic diseases like sickle cell disease, where patients have unusually shaped red blood cells, is already in use. Newsweek/Getty Images/Newsweek/Getty Images "This type of selection of specific embryos as a result of IVF is already occurring in sickle cell care," Dr. Crawford Strunk, vice chief medical officer of the Sickle Cell Disease Association of America, told Newsweek. Parents are able to choose an embryo which tests negative for sickle cell disease, he said, and from which stem cells can also be taken for transplant to help cure children with the condition. However, two experts raised concern over embryo selection, with one telling Newsweek that there are "deeply troubling ethical aspects" of IVF. Preventing Genetic Disease and Improving Embryo Health Nucleus Embryo is described as "the first genetic optimization software that helps parents pursuing IVF see and understand the complete genetic profile of each of their embryos." With the tool, users can check for more than 1,000 traits and conditions, from single gene disorders like cystic fibrosis to complex conditions like heart disease and cancer risks, and mental health conditions like anxiety and ADHD, the company's CEO Kian Sadeghi told Newsweek. The technology is able to do this by not only detecting specific genetic markers for certain diseases but by also calculating polygenic scores, which combine up to a million genetic markers into a single number to determine someone's genetic predisposition for a condition or trait. This includes coronary artery disease, breast cancer, type 2 diabetes and more. "These integrated models further enable Nucleus to identify risk in embryos and adults as accurately as possible," Jerry Lanchbury, a member of Nucleus' scientific advisory board, told Newsweek. According to a 2023 study by Rady Children's Institute for Genomic Medicine, the deaths of five out of seven infants from genetic disease could have been prevented had "rapid, diagnostic [whole genome sequencing] been performed at the time of symptom onset or intensive care unit admission." In the U.K., whole genome sequencing has been brought in as a routine part of medical care, in order to increase "early detection and treatment of high-risk conditions." "The power of genetic prediction also goes beyond rare diseases. Genetic testing can lead to lifesaving preventive care," Lanchbury said. He added that genetic instances of high cholesterol, breast cancer and colon cancer cause a substantial number of deaths in the U.S. every year, with more than 3 million cases contributing to over 750,000 deaths per year. "Each of these conditions are preventable," he said. Lanchbury also said that "the environment, parenting and chance play profound roles in how genetic predispositions manifest," so Nucleus ranks its predictions by strength so that parents can understand the range of likely outcomes for their embryos. Debbie Wasserman Schultz, U.S. representative for Florida, told Newsweek that IVF can be a "godsend" for those with a BRCA gene mutation—which can increase the risk of breast cancer in women by 80 percent, Lanchbury said. A breast cancer survivor herself, Wasserman Schultz added that IVF treatment "can help end generational genetic cycles of deadly disease in a family's future." Technology that can test for a BRCA gene mutation in embryos and determine which embryos should be implanted as a result is "one of many incredible, life-saving benefits of genetic research," she said. However, while Sadeghi told Newsweek that "people have the right to genetically optimize their children," various groups and experts say the technology raises a number of ethical questions. A photo of a Nucleus kit, used to screen embryos for genetic conditions. A photo of a Nucleus kit, used to screen embryos for genetic conditions. Uncredited/Nucleus Choosing Embryos Based on Characteristics While giving parents the opportunity to select their embryos based on a number of traits and conditions could help to reduce the prevalence of genetic disease, it could also allow them to make their choices based on other factors. "If we are talking about screening and selecting certain human embryos over others based on a host of characteristics and risks, then we are not talking about preventing harm to future human beings but making a choice as to which human lives are most worth living," Jason Thacker, assistant professor of philosophy and ethics at Southern Seminary and Boyce College, told Newsweek. He added that from the very moment of fertilization, "a unique human being is made which has inherent dignity, value and rights." "This is one of the deeply troubling ethical aspects of IVF in general, where children are often treated as mere commodities and not fully human in the embryonic stage," he said. He added that while modifying genes to prevent disease "may have some tangible benefits worth cautiously pursuing," it is also important to be aware of how those decisions will affect the child and subsequent generations. There has also been some concern raised about the implications of parents selecting embryos with a higher IQ screening. "Parents can select for an average difference of 2.5 IQ points," Sadeghi told Newsweek. However, intelligence has been found to be linked with schizophrenia, ADHD, OCD, Alzheimer's disease and autism, he added. "When you analyze genes for disease risk, you're also uncovering insights into traits, since both share a common genetic foundation," Sadeghi said. "What matters most to us is helping parents understand these genetic connections—so they can make informed choices based on what matters most to them." Thacker, however, warned that this technology was leading society into territory where "we will not always be able to accurately predict the downstream effects of our biomedical decisions, and we must be extremely cautious and seek wisdom as we go about techniques that affect real human lives—both in the embryonic stage, at birth and into future generations." A photo of a computer screen showing the results from an embryo assessment done by the company Nucleus. A photo of a computer screen showing the results from an embryo assessment done by the company Nucleus. Uncredited/Nucleus IVF Treatment and Unused Embryos Some concern, particularly from religious groups, has been raised over the fact that this technology could result in unused embryos being destroyed. According to calculations by the Catholic television network EWTN, more embryos are likely destroyed during IVF treatment than via abortion each year. Catholic belief determines a new human life begins at the point of conception or fertilization, meaning the loss of these embryos equates to a loss of human life, making IVF itself an ethical issue. "IVF is morally condemned because it replaces, rather than assists, the sexual act of the couple in conceiving children and creates human life in a lab where the embryos are easily mistreated and even killed," Joseph Meaney, a past president and current senior fellow of the National Catholic Bioethics Center, told Newsweek. Meaney said gene therapy for embryos could be ethical as long as it was done to "treat or cure a genetic or medical defect." However, "It is not ethically acceptable to make genetic modifications to normal human beings with the intention of enhancement—defined as trying to create better than healthy human capacity," Meaney said, pointing to those who may wish to select embryos based on higher intelligence for example. Aware of these concerns, Sadeghi told Newsweek that Nucleus intends to overcome the issues "openly, transparently, and always guided by individual choice." "Everything we do is guided on the principle of responsible use of modern genomic science, and reproductive freedom," he added. Sadeghi said that until now, this sort of technology "has been discussed only behind closed doors—not in public." This means that Americans now have the opportunity to "listen to each other, hear each other out, and use this information to establish their views to ensure the insight Nucleus Embryo can provide is put to good use."
Miami Herald
18 hours ago
- Miami Herald
Walmart Products Recalled Nationwide as Customers Told to Dispose of Items
Two products sold at Walmart have been recalled, with customers being urged to dispose of the items. Guidance on the product recall page on Walmart's website reads: "Walmart and Sam's Club are committed to the health and safety of our customers and members and to providing products that are safe and compliant, all supported by our health and wellness, product safety, and food safety professionals." "In the event of a product recall, we work swiftly to block the item from being sold and remove it from our stores and clubs." Newsweek reached out to Walmart via an online contact form for comment. Using recalled products or consuming recalled food items can pose serious health risks. Recalls can be initiated for myriad reasons, including undeclared allergens or potential contaminants. The Consumer Product Safety Commission (CPSC) has announced a recall of approximately 8,560 MaxKare Electric Blankets, sold exclusively online at between June 2021 and November 2024, for $27 to $80. The recall targeted models HB18A-7284-1, HB18A-8490-2, and HB18A-6284-1, which were available in three sizes (twin, full, queen) and two colors (brown and gray). Yumo, which manufactures the blankets, received 34 reports of the blankets overheating, including two reports of blankets catching fire and three reports of burn injuries. The affected blankets featured six heating levels and a nine-hour auto-off function. Shenzhen Yumo Commerce and Trade Corporation manufactured the blankets in China. Consumers should immediately stop using the product and are advised to contact Yumo for instructions on how to dispose of it. Newsweek reached out to Yumo via email for comment. The U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) issued a recall for FreshRealm's Chicken Fettuccine Alfredo products and is investigating an outbreak of Listeria connected to the recall. In response to a request for comment, Fresh Realm directed Newsweek to a press release that read in part: "Out of an abundance of caution, FreshRealm is recalling the product while the investigation proceeds. The investigation will focus on how Listeria may have entered the product, and whether it entered from a FreshRealm facility, or through any of the ingredients that FreshRealm received from external ingredient suppliers." "FreshRealm remains committed to the highest standards of food safety and is working closely with the Food and Drug Administration, the U.S. Department of Agriculture Food Safety and Inspection Service and the Centers for Disease Control and Prevention to provide full transparency and access throughout the process." The recall affected three different ready-to-eat products: MARKETSIDE GRILLED CHICKEN ALFREDO WITH FETTUCCINE Tender Pasta with Creamy Alfredo Sauce, White Meat Chicken and Shaved Parmesan Cheese Details: 32.8oz, best-by—date of 6.27.25, EST. P-50784 MARKETSIDE GRILLED CHICKEN ALFREDO WITH FETTUCCINE Tender Pasta with Creamy Alfredo Sauce, White Meat Chicken, Broccoli and Shaved Parmesan Cheese Details: 12.3oz, 6.26.25, EST. P-47770 HOME CHEF Heat & Eat Chicken Fettuccine Alfredo with pasta, grilled white meat chicken, and Parmesan cheese Details: 12.05oz, 6.19.25, EST. P-47718 Consumers who purchased the product are advised to destroy it or return it to the place of purchase for a refund. The FSIS said in their recall notice that they are "investigating an outbreak of Lm that currently includes 17 ill people in 13 states. As of June 17, 2025, there have been three reported deaths and one fetal loss associated with this outbreak. "The outbreak strain of Lm was isolated from ill people on dates ranging from August 2024 – May 2025. The same outbreak strain was isolated from a routine chicken fettuccine alfredo sample collected by FSIS in a FreshRealm establishment in March 2025. The lot of chicken fettuccine alfredo represented by this sample was held during sampling, destroyed, and never entered commerce." The FSIS, on its website: "Listeriosis can cause fever, muscle aches, headache, stiff neck, confusion, loss of balance and convulsions sometimes preceded by diarrhea or other gastrointestinal symptoms. An invasive infection spreads beyond the gastrointestinal tract. "In pregnant women, the infection can cause miscarriages, stillbirths, premature delivery or life-threatening infection of the newborn. In addition, serious and sometimes fatal infections in older adults and people with weakened immune systems. Listeriosis is treated with antibiotics." Both recalls are ongoing. Related Articles How Recall of 20 Million Eggs Could Affect US PricesWalmart's Post About Grilling Flooded With Negative CommentsWalmart Faces MAGA Boycott After Heiress Funds 'No Kings' AdRetail Layoffs Soar Nearly 300% So Far This Year 2025 NEWSWEEK DIGITAL LLC.
